참고문헌
- Ahn M J, Park C K, Choi J H, et al (2001). Clinical significance of microvessel density in multiple myeloma patients. J Korean Med Sci, 16, 45-50. https://doi.org/10.3346/jkms.2001.16.1.45
- Alexandrakis MG, Passam FH, Dambaki C, et al (2004). The relation between bone marrow angiogenesis and the proliferation index Ki-67 in multiple myeloma. J Clin Pathol, 57, 856-60. https://doi.org/10.1136/jcp.2003.013110
- Dispenzieri A, Lacy MQ, Greipp PR (2009). Multiple myeloma In 'Wintrobe's Clinical Hematology 12th ed' Eds. John P. Greer et al. Walnut street, Philadelphia. (pp 2372-80).
- Drach J, Gattringer C, Glassl H, Drach D Huber H (1992). The biological and clinical significance of Ki-67 growth fraction in multiple myeloma. Hematol Oncol, 10, 125-134. https://doi.org/10.1002/hon.2900100209
- Fernando RC, de Carvalho F, Mazzotti DR, Evangelista AF, Braga WM et al (2015). Multiple myeloma cell lines and primary tumors proteoma: protein biosynthesis and immune system as potential therapeutic targets. Genes Cancer, 6, 462-71.
- International Myeloma Working Group (2003). Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working group. Br J Hematol, 121, 749-57. https://doi.org/10.1046/j.1365-2141.2003.04355.x
- Kumar L, Vikram P, Kochupillai V (2006). Recent advances in the management of multiple myeloma. Natl Med J India, 19, 80-9.
- Kyle R, Gertz MA, Witzig T, et al (2003). Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc, 78, 21-33. https://doi.org/10.4065/78.1.21
- Lai R, Medeiros LJ, Wilson CS, et al (1998). Expression of the cell-cycle-related proteins E2F-1, p53, mdm-2, p21waf-1, and Ki-67 in multiple myeloma: correlation with cyclin-D1 immunoreactivity. Mod Pathol, 11, 642-7.
- Lee N, Lee H, Moon SY, et al (2015). Adverse prognostic impact of bone marrow microvessel density in multiple myeloma. Ann Lab Med, 35, 563-9. https://doi.org/10.3343/alm.2015.35.6.563
- Lokhorst H, Boom S, Terpstra W, et al (1988). Determination of the growth fraction in monoclonal gammopathy with the monoclonal antibody Ki-67. Br J Haematol, 69, 477-81. https://doi.org/10.1111/j.1365-2141.1988.tb02402.x
- Mark TM, Forsberg P, Ouansafi I, et al (2014). The Ki67/CD138 ratio independently predicts overall survival in the upfront treatment of newly diagnosed multiple myeloma. Blood, 124, 2016-6.
- Markovic O, Marisavljevic D, Cemerikic V, et al (2005). Proliferative activity of myeloma cells determined by Ki-67 antibody: biological and clinical significance. Vojnosanit Pregl, 62, 33-8. https://doi.org/10.2298/VSP0501033M
- Medinger M, Passweg J (2014). Role of tumor angiogenesis in hematological malignancies. Swiss Med Wkly, 144.
- Pruneri G, Bertolini F, Soligo D, et al (1999). Angiogenesis in myelodysplastic syndromes. Br J Cancer, 81, 1398-401. https://doi.org/10.1038/sj.bjc.6693515
- Rajkumar SV, Leong T, Roche PC, et al (2000). Prognostic value of bone marrow angiogenesis in multiple myeloma. Clin Cancer Res, 6, 3111-6.
- Rajkumar SV, Mesa RA, Fonseca R, et al (2002). Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis. Clin Cancer Res, 8, 2210-16.
- Richardson PG, Mark TM, Lacy MQ (2013). Pomalidomide: new immunomodulatory agent with potent antiproliferative effects. Crit Rev Oncol Hematol, 88, 36-44. https://doi.org/10.1016/j.critrevonc.2013.02.001
- Sezer O, Niemoller K, Eucker J, et al (2000). Bone marrow microvessel density is a prognostic factor for survival in patients with multiple myeloma. Ann Hematol, 79, 574-7. https://doi.org/10.1007/s002770000236
- Sridevi HB, Rai S, Suresh PK, Somesh MS, Minal J (2015). Pancytopenia in multiple myeloma- an enigma: our experience from tertiary care hospital. J Clin Diagn Res, 9, 4-6.
- Tichy M, Ticha V, Scudla V, Svachova M, Zapletalova J (2010). Analysis of bone marrow angiogenesis in multiple myeloma. Cesk Patol, 46, 15-9.
- Vacca A, Ribatti D, Roncali L, et al (1994). Bone marrow angiogenesis and progression in multiple myeloma. Br J Hematol, 87, 503-8. https://doi.org/10.1111/j.1365-2141.1994.tb08304.x
- Xu JL, Lai R, Kinoshita T, Nakashima N, Nagasaka T (2002). Proliferation, apoptosis, and intratumoral vascularity in multiple myeloma: correlation with the clinical stage and cytological grade. J Clin Pathol, 55, 530-4. https://doi.org/10.1136/jcp.55.7.530